The Cytomegalovirus Breastfeeding Safety Advice
The Cytomegalovirus Breastfeeding Safety Advice The Cytomegalovirus (CMV) is a common virus belonging to the herpesvirus family, with most individuals infected at some point in their lives. For mothers and their infants, particularly during breastfeeding, understanding the implications of CMV is essential to ensure safety and make informed decisions. While CMV generally remains dormant in healthy individuals, it can pose risks to vulnerable populations, especially newborns and immunocompromised infants.
When a mother is infected with CMV, the virus can be present in her bodily fluids, including blood, urine, saliva, and breast milk. Notably, CMV can be shed into breast milk during active infection, which raises questions about the safety of breastfeeding in such cases. Despite the potential for transmission, the Centers for Disease Control and Prevention (CDC) and other health organizations advocate for continued breastfeeding because the benefits often outweigh the risks, especially in full-term infants.
The primary concern with CMV transmission through breast milk is its potential to cause congenital or postnatal infections. While most healthy, full-term infants are exposed to CMV via breastfeeding without significant health issues, preterm or low birth weight infants are at a higher risk of developing more severe symptoms. These can include jaundice, hepatosplenomegaly, pneumonia, or even hearing loss. Consequently, healthcare providers may advise additional precautions for these high-risk infants.
To mitigate risks, mothers who are known to have active CMV infections or are seropositive and shedding the virus in their breast milk might consider certain preventive strategies. These can include freezing expressed breast milk, as some studies suggest that freezing can reduce viral activity, although it does not eliminate the virus entirely. Pasteurization, a process commonly used in milk banks, effectively inactivates CMV but also destroys beneficial antibodies and nutrients, making it less suitable for routine use outside of clinical settings.
Healthcare professionals often recommend that mothers with active CMV infections or whose infants are preterm consult with their pediatrician or infectious disease specialist. Close monitoring of the infant’s health, testing for CMV, and assessing the risk versus benefit of continued breastfeeding are crucial steps. In some cases, alternatives such as formula feeding may be temporarily advised, especially if the infant is at high risk or shows signs of CMV infection.
Despite these precautions, it’s important to emphasize that breastfeeding remains a highly beneficial practice, providing essential nutrients and immune factors that support infant development and health. The decision to breastfeed when CMV is involved should be individualized, considering the mother’s health, the infant’s gestational age, and overall risk factors. Open communication with healthcare providers ensures that mothers can make the best choices, balancing the benefits of breastfeeding with safety concerns.
In summary, while CMV can be present in breast milk, the overwhelming consensus is that breastfeeding is safe and beneficial for most infants. High-risk cases require tailored advice and precautions, but for the majority, the advantages of breastfeeding far outweigh potential risks. Staying informed and consulting healthcare professionals ensures that mothers can confidently nurture their babies while minimizing any potential health issues associated with CMV.
